Price Movement Focus: Social media chatter around DCGO has centered on the stock's recent decline to approximately 0.65 amid broader selling activity. Participants described short-term holders exiting positions, contributing to the downward pressure observed in recent sessions.
Market Sentiment Shift: Discussions emphasized the volatility, with some noting how paper hands amplified the moves during the drop. Overall, the tone reflected caution as traders monitored further developments in the healthcare services sector.
Note: This discussion summary was generated from an AI condensation of post data.
DocGo Revenue
DocGo had revenues of $75.6M in Q1 2026. This is a decrease of -21.33% from the same period in the prior year.
You can track DCGO financials on Quiver Quantitative's DCGO stock page.
You can access data on DCGO stock through the Quiver Quantitative API.
DocGo Hedge Fund Activity
We have seen 57 institutional investors add shares of DocGo stock to their portfolio, and 49 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 4,911,965 shares (-77.2%) from their portfolio in Q2 2026, for an estimated $2,535,065
- STATE STREET CORP removed 1,545,524 shares (-78.6%) from their portfolio in Q2 2026, for an estimated $797,644
- PEAPOD LANE CAPITAL LLC added 1,370,924 shares (+121.4%) to their portfolio in Q2 2026, for an estimated $707,533
- RENAISSANCE TECHNOLOGIES LLC added 944,826 shares (+167.1%) to their portfolio in Q1 2026, for an estimated $594,390
- GSA CAPITAL PARTNERS LLP added 660,639 shares (+193.6%) to their portfolio in Q2 2026, for an estimated $340,955
- AQR CAPITAL MANAGEMENT LLC added 583,365 shares (+384.1%) to their portfolio in Q1 2026, for an estimated $366,994
- MORGAN STANLEY removed 479,531 shares (-78.1%) from their portfolio in Q1 2026, for an estimated $301,672
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
DocGo Analyst Ratings
Wall Street analysts have issued reports on $DCGO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 05/11/2026
To track analyst ratings and price targets for DocGo, check out Quiver Quantitative's $DCGO forecast page.
DocGo Price Targets
Multiple analysts have issued price targets for $DCGO recently. We have seen 4 analysts offer price targets for $DCGO in the last 6 months, with a median target of $2.75.
Here are some recent targets:
- Richard Close from Canaccord Genuity set a target price of $1.0 on 03/25/2026
- Ryan MacDonald from Needham set a target price of $3.0 on 03/17/2026
- David Grossman from Stifel set a target price of $2.5 on 03/17/2026
- Sarah James from Cantor Fitzgerald set a target price of $3.0 on 03/17/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
